Nanette Wenger

Q: What Schools Are Affiliated With Nanette Wenger

Nanette Wenger is affiliated with the following schools: Harvard University, Emory University

Nanette Wenger's AcademicInfluence.com Rankings

Nanette Wenger

Philosophy

#3681

World Rank

#5901

Historical Rank

Logic

#1326

World Rank

#2048

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Nanette Wenger's Degrees

Doctorate Medicine Harvard University

Why Is Nanette Wenger Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Nanette Kass Wenger is an American clinical cardiologist and professor emerita at Emory University School of Medicine in Atlanta, Georgia. Early life and education Nanette Wenger was born September 3, 1930, in New York City to parents who had emigrated from Russia to the United States and settled in New York. Her early education was in the New York City public schools. In 1951 she graduated summa cum laude from Hunter College in New York. She received her doctor of medicine degree from Harvard Medical School in 1954 as one of their first female graduates, and began her postgraduate work at Mount Sinai Hospital in New York, where she became the first woman to be chief resident in the cardiology department. After her residency, she moved to Emory University, where she started as an instructor and eventually was named full professor of medicine in 1971.

(See a Problem?)

Nanette Wenger's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

K/DOQI clinical practice guidelines for chronic kidney disease (2002) (8858)
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. (2005) (3308)
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. (2003) (2521)
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) (2339)
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) (2334)
Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Ph (2003) (2115)
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie (2007) (1962)
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). (2002) (1878)
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. (1986) (1844)
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. (2011) (1730)
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2010) (1612)
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2010) (1269)
Assessment of quality of life in clinical trials of cardiovascular therapies. (1984) (1207)
2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Forc (2012) (1056)
K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease (2004) (1050)
Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. (1998) (979)
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) (941)
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. (2011) (895)
Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. (2007) (893)
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. (2007) (873)
Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women (2006) (825)
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women (2004) (788)
Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. (2011) (761)
Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association (2016) (742)
Cardiovascular health and disease in women. (1993) (731)
Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement Study (2000) (696)
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2011) (595)
2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (590)
Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. (2012) (585)
Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. (2005) (562)
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women (2004) (492)
2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in c (2011) (474)
2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in c (2011) (474)
Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. (2001) (445)
Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade (2017) (421)
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2011) (420)
Effects of Testosterone Treatment in Older Men. (2016) (407)
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2010) (391)
Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. (1992) (386)
Secondary Prevention of Coronary Heart Disease in the Elderly (With Emphasis on Patients ≥75 Years of Age): An American Heart Association Scientific Statement From the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention (2002) (320)
2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in (2011) (309)
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2013) (299)
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study. (2008) (295)
Prehypertension and Cardiovascular Disease Risk in the Women's Health Initiative (2007) (292)
Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone (2017) (277)
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. (2007) (266)
Evidence-based guidelines for cardiovascular disease prevention in women. (2004) (243)
Comparative Effectiveness of Exercise Electrocardiography With or Without Myocardial Perfusion Single Photon Emission Computed Tomography in Women With Suspected Coronary Artery Disease: Results From the What Is the Optimal Method for Ischemia Evaluation in Women (WOMEN) Trial (2011) (240)
Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. (2009) (236)
The electrocardiogram in acute pulmonary embolism. (1975) (222)
Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit? (2004) (216)
Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. (2006) (214)
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (2011) (214)
Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus: A Scientific Statement From the American Heart Association. (2015) (212)
Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Ischemic Heart Disease: A Consensus Statement From the American Heart Association (2014) (212)
Cardiac care for older adults. Time for a new paradigm. (2011) (211)
Changing Clinical Characteristics of Coronary Surgery Patients Differences Between Men and Women (1993) (198)
Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. (2001) (194)
The Physician's Role in Minimizing Prehospital Delay in Patients at High Risk for Acute Myocardial Infarction: Recommendations from the National Heart Attack Alert Program (1997) (194)
Cardiovascular disease in women. (1993) (192)
Design and methods of the Raloxifene Use for The Heart (RUTH) study. (2001) (179)
Cardiac rehabilitation and risk reduction: time to "rebrand and reinvigorate". (2015) (179)
Effect of High-Dose Atorvastatin on Hospitalizations for Heart Failure: Subgroup Analysis of the Treating to New Targets (TNT) Study (2007) (177)
Time course of depression and outcome of myocardial infarction. (2006) (173)
Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. (2008) (166)
Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists: A Presidential Advisory From the American Heart Association and the American College of Obstetricians and Gynecologists (2018) (164)
Cardiac rehabilitation as secondary prevention. Agency for Health Care Policy and Research and National Heart, Lung, and Blood Institute. (1995) (162)
Chronic kidney disease and cognitive impairment in menopausal women. (2005) (161)
Women and coronary heart disease: a century after Herrick: understudied, underdiagnosed, and undertreated. (2012) (157)
Determinants of Residual Risk in Secondary Prevention Patients Treated With High- Versus Low-Dose Statin Therapy: The Treating to New Targets (TNT) Study (2012) (157)
Cardiac rehabilitation as secondary prevention (1995) (156)
Coronary heart disease in African Americans. (2001) (156)
Ischemic heart disease in women: a focus on risk factors. (2015) (147)
Coronary heart disease: an older woman's major health risk (1997) (145)
You've come a long way, baby: cardiovascular health and disease in women: problems and prospects. (2004) (144)
Outcomes of Using High- or Low-Dose Atorvastatin in Patients 65 Years of Age or Older with Stable Coronary Heart Disease (2007) (141)
Cardiovascular outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II) (2002) (140)
Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions. (2006) (136)
Domain Management Approach to Heart Failure in the Geriatric Patient: Present and Future. (2018) (136)
Coronary heart disease: the female heart is vulnerable. (2003) (135)
Lessons From the Testosterone Trials (2018) (133)
Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action. (2020) (133)
Hypertension Across a Woman's Life Cycle. (2018) (128)
Rehabilitation of the coronary patient. (1981) (126)
Percutaneous transluminal coronary angioplasty in women compared with men. (1994) (125)
Current status of cardiac rehabilitation. (2008) (122)
Coronary embolism: review of the literature and presentation of fifteen cases. (1958) (120)
Gender, coronary artery disease, and coronary bypass surgery. (1990) (119)
K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease: Work group membership (2005) (118)
Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart Trial: Results of Subgroup Analyses by Age and Other Factors (2009) (115)
What to Expect From the Evolving Field of Geriatric Cardiology. (2015) (114)
Transient cerebral ischemia due to arrhythmia. (1970) (107)
Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials. (2006) (104)
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: tests for silent and inducible ischemia: Writing Group II. (2000) (101)
The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. (1999) (100)
The electrocardiogram in normal pregnancy. (1981) (95)
The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men (2014) (94)
Effect of Raloxifene on Stroke and Venous Thromboembolism According to Subgroups in Postmenopausal Women at Increased Risk of Coronary Heart Disease (2009) (94)
Maternal recall of hypertensive disorders in pregnancy: a systematic review. (2013) (89)
Gender Differences in Atrial Fibrillation: A Review of Epidemiology, Management, and Outcomes (2019) (86)
Cardiovascular Complications of Pregnancy (2015) (84)
Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden (2018) (83)
Clinical characteristics of coronary heart disease in women: emphasis on gender differences. (2002) (83)
Subgroup Interactions in the Heart and Estrogen/Progestin Replacement Study: Lessons Learned (2002) (82)
Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial. (2002) (82)
Relation of three genetic traits to venous thrombosis in an African-American population. (1998) (81)
Secondary prevention of coronary heart disease in elderly patients. (2005) (81)
The Metabolic Syndrome in African Americans: a review. (2003) (79)
Hormone and nonhormone therapy for the maintenance of postmenopausal health: the need for randomized controlled trials of estrogen and raloxifene. (1998) (78)
Physician practice in the management of patients with uncomplicated myocardial infarction: changes in the past decade. (1982) (77)
Risk stratification after myocardial infarction. (1993) (77)
The Effect of Testosterone on Cardiovascular Biomarkers in the Testosterone Trials (2018) (75)
Women and heart disease, the underrecognized burden: sex differences, biases, and unmet clinical and research challenges. (2016) (73)
Correlates of Sexual Satisfaction Among Sexually Active Postmenopausal Women in the Women’s Health Initiative-Observational Study (2008) (72)
ACCF/AHA Focused Update 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (2011) (71)
Quality and Equitable Health Care Gaps for Women: Attributions to Sex Differences in Cardiovascular Medicine. (2017) (71)
Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery. (2008) (71)
Massive acute pulmonary embolism. The deceivingly nonspecific manifestations. (1972) (70)
Hypertension and other cardiovascular risk factors in women. (1995) (70)
Differences in symptom presentation and hospital mortality according to type of acute myocardial infarction. (2012) (68)
Women, Stress, and Heart Disease (1998) (66)
Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk. (2008) (66)
Review of the International Position Paper on Women's Health and Menopause: a comprehensive approach. (2003) (65)
Comparison of 80 versus 10 mg of atorvastatin on occurrence of cardiovascular events after the first event (from the Treating to New Targets [TNT] trial). (2010) (65)
Preferred Practices and Performance Measures for Measuring and Reporting Care Coordination: A Consensus Report (2010) (64)
A racial difference in the prevalence of the Arg506-->Gln mutation. (1996) (63)
The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism. (2000) (62)
Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease—state-of-the-evidence and clinical recommendations (2017) (60)
Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study (2007) (59)
Exclusion of the elderly and women from coronary trials. Is their quality of care compromised? (1992) (58)
Prevalence of the prothrombin 20210 G-to-A variant in blacks: infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects. (1998) (58)
Quality of life: can it and should it be assessed in patients with heart failure? (1989) (57)
Report of the National Heart, Lung, and Blood Institute Working Group on Sex Differences Research in Cardiovascular Disease: Scientific Questions and Challenges (2016) (55)
Coronary Heart Disease in Women: Update 2008 (2008) (55)
Race, gender, and mortality in adults > or =65 years of age with incident heart failure (from the Cardiovascular Health Study). (2009) (54)
Coronary disease in women. (1985) (54)
Recognizing pregnancy-associated cardiovascular risk factors. (2014) (53)
Acute Coronary Syndromes in the Elderly (2017) (52)
Medical Director Responsibilities for Outpatient Cardiac Rehabilitation/Secondary Prevention Programs: A Scientific Statement From the American Heart Association/American Association for Cardiovascular and Pulmonary Rehabilitation (2005) (51)
Return to work after coronary bypass surgery. (1983) (51)
Sexual satisfaction and cardiovascular disease: the Women's Health Initiative. (2008) (50)
Relationship of venous thromboembolism and myocardial infarction with the renin‐angiotensin system in African‐Americans (2002) (50)
Uncomplicated myocardial infarction. Current physician practice in patient management. (1973) (50)
Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women’s Health Initiative (2018) (50)
Coronary heart disease in women, randomized clinical trials, HERS and RUTH. (1998) (48)
Physical activity and structured exercise for patients with stable ischemic heart disease. (2013) (48)
Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists (2011) (47)
Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists (2016) (47)
Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans. (2000) (46)
Women, Hypertension, and the Systolic Blood Pressure Intervention Trial. (2016) (45)
Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease. (2016) (44)
Safety and efficacy of ezetimibe added to atorvastatin versus up titration of atorvastatin to 40 mg in Patients > or = 65 years of age (from the ZETia in the ELDerly [ZETELD] study). (2010) (44)
Is there a bias against performing coronary revascularization in women? (1996) (43)
Autoimmune Studies in Patients with Primary Myocardial Disease (1968) (43)
Appropriateness of Quality Indicators for Older Patients with Advanced Dementia and Poor Prognosis (2003) (43)
Focused Cardiovascular Care for Women: The Need and Role in Clinical Practice. (2016) (42)
Gerotechnology for Older Adults With Cardiovascular Diseases: JACC State-of-the-Art Review. (2020) (42)
Early risks of hormone therapy in patients with coronary heart disease. (2000) (42)
Statins for Primary Prevention in Older Adults—Moving Toward Evidence‐Based Decision‐Making (2018) (41)
Prevention of Cardiovascular Disease: Highlights for the Clinician of the 2013 American College of Cardiology/American Heart Association Guidelines (2014) (40)
Prediction of Cardiovascular Events in Statin-Treated Stable Coronary Patients of the Treating to New Targets Randomized Controlled Trial by Lipid and Non-Lipid Biomarkers (2014) (40)
Changes in plasma cholesterol levels after hospitalization for acute coronary events. (1996) (40)
Primary atrial tumor. Evaluation of clinical findings in ten cases and review of the literature. (1963) (40)
Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials. (2007) (39)
CARDIOVASCULAR TOXICITY * (1965) (39)
Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III) (1998) (39)
Electrocardiographic changes during routine sigmoidoscopy. (1968) (38)
Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study (2009) (38)
Effects of sex and gender on adaptation to space: cardiovascular alterations. (2014) (37)
Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers. (2011) (36)
Aortic valve disease in the older adult (2016) (36)
Coronary heart disease in women: highlights of the past 2 years—stepping stones, milestones and obstructing boulders (2006) (36)
Low-Fat Dietary Pattern Intervention and Health-Related Quality of Life: The Women's Health Initiative Randomized Controlled Dietary Modification Trial. (2016) (36)
Shared decision‐making for older adults with cardiovascular disease (2019) (35)
Impact of female sex on lipid lowering, clinical outcomes, and adverse effects in atorvastatin trials. (2015) (35)
Hypertension During Pregnancy (2020) (34)
Quality of life issues in hypertension: consequences of diagnosis and considerations in management. (1988) (34)
Rehabilitation after myocardial infarction. (1979) (33)
Review of the treatment of acute coronary syndrome in elderly patients (2009) (33)
Women, heart failure, and heart failure therapies. (2002) (33)
Management of hypertension in women (2012) (32)
Sex Differences in Cardiovascular Disease and Cognitive Impairment: Another Health Disparity for Women? (2019) (31)
Stadium coronary care. A concept in emergency health care delivery. (1972) (30)
Racial differences in the use of invasive coronary procedures after acute myocardial infarction in Medicare beneficiaries. (1993) (30)
Creatinine levels and cardiovascular events in women with heart disease: do small changes matter? (2004) (29)
Comprehensive primary prevention of cardiovascular disease in women (2017) (29)
Cardiac rehabilitation and cardiovascular disability: role in assessment and improving functional capacity: a position statement from the American Association of Cardiovascular and Pulmonary Rehabilitation. (2013) (28)
Sulfadiazine rheumatic fever prophylaxis during pregnancy: does it increase the risk of kernicterus in the newborn? (1980) (28)
What do the recent American Heart Association/American College of Cardiology Foundation Clinical Practice Guidelines tell us about the evolving management of coronary heart disease in older adults? (2013) (27)
Coronary artery disease in women. (1988) (27)
Gender disparity in cardiovascular disease: bias or biology? (2012) (27)
Mutations in the genes regulating methylene tetrahydrofolate reductase (MTHFR C-->T677) and cystathione beta-synthase (CBS G-->A919, CBS T-->c833) are not associated with myocardial infarction in African Americans. (2001) (26)
Cardiovascular Disease in the Elderly (1992) (26)
Rheumatic fever chemoprophylaxis and penicillin-resistant gingival organisms. (1970) (25)
Secondary prevention of coronary heart disease. (1998) (25)
ELECTROCARDIOGRAPHIC CHANGES IN PREGNANCY. (1964) (25)
Feasibility of a Smartphone-enabled Cardiac Rehabilitation Program in Male Veterans With Previous Clinical Evidence of Coronary Heart Disease. (2018) (25)
Treatment of heart failure in African Americans--a call to action. (2011) (24)
Rehabilitation of the patient with coronary heart disease. New information for improved care. (1989) (24)
Pericardial disease in the elderly. (1992) (24)
The care of elderly patients with cardiovascular disease. (1988) (24)
Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years (2014) (24)
Prevalence of silent myocardial ischemia and arrhythmias in patients with coronary heart disease undergoing gastrointestinal tract endoscopic procedures. (1993) (24)
Coronary heart disease in women: a 'new' problem. (1992) (23)
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non–ST‐Elevation Myocardial Infarction (Updating the 2007 Guideline): Highlights for the Clinician (2012) (23)
Cardiovascular disease prevention tailored for women (2008) (22)
Identifying the Critical Gaps in Research on Sex Differences in Metabolism Across the Life Span (2018) (22)
Impact of the Coronary Drug Project findings on clinical practice. (1983) (22)
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. (2007) (22)
The metabolic syndrome: recognition and management. (2006) (22)
Viral antibodies in patients with primary myocardial disease. (1968) (22)
Coronary heart disease in women: gender differences in diagnostic evaluation. (1994) (21)
Rehabilitation of the coronary patient: status 1986. (1986) (21)
Clinical presentation of CAD and myocardial ischemia in women (2016) (21)
Pacemaker twiddler's syndrome. (1989) (21)
A comparative analysis of premature heart disease- and cancer-related mortality in women in the USA, 1999-2018. (2021) (21)
Mitral valve prolapse and ophthalmoplegia: a progressive, cardioneurologic syndrome. (1980) (21)
Women and heart disease: knowledge, worry, and motivation. (2011) (20)
The 2014 American College of Cardiology ACC/American Heart Association Guideline for the Management of Patients With Non–ST‐Elevation Acute Coronary Syndromes (2015) (20)
Myocardial infarction with and without laboratory documentation--one year prognosis. (1976) (20)
Women in cardiology: the US experience (2005) (20)
Sex-specific effects of diabetes on adverse outcomes after percutaneous coronary intervention: trends over time. (2007) (20)
An update on coronary heart disease in women. (1998) (20)
Exercise as a therapeutic intervention in patients with stable ischemic heart disease: an underfilled prescription. (2014) (20)
THE SKULL ROENTGENOGRAM IN IRON DEFICIENCY ANEMIA AND IN SECONDARY POLYCYTHEMIA. (1965) (20)
Preventing Cardiovascular Disease in Women: An Update (2008) (19)
The female heart is vulnerable to cardiovascular disease: emerging prevention evidence for women must inform emerging prevention strategies for women. (2010) (19)
Coronary heart disease in the elderly: Review of current knowledge and research recommendations (1988) (19)
Early ambulation: the physiologic basis revisited. (1982) (19)
Improved Cardiovascular Disease Outcomes in Older Adults (2016) (19)
Physical inactivity and coronary heart disease in elderly patients. (1996) (19)
Women and atrial fibrillation (2020) (19)
Use of Statin Therapy to Reduce Cardiovascular Risk in Older Patients (2010) (19)
Is Diabetes Mellitus a Heart Disease Equivalent in Women?: Results From an International Study of Postmenopausal Women in the Raloxifene Use for the Heart (RUTH) Trial (2013) (19)
Taking a Giant Step Toward Women's Heart Health: Finding Policy Solutions to Unanswered Research Questions. (2015) (19)
Postmenopausal hormone therapy. Is it useful for coronary prevention? (1998) (18)
Quality of life: concept and approach to measurement. (1986) (18)
Enrollment and maintenance of elderly patients in cardiovascular clinical trials. (2006) (17)
Alice in lipidland: the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol. (2014) (17)
Coronary Heart Disease and Women: Magnitude of the Problem (2002) (17)
Management of Women With Acquired Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 3/5. (2021) (17)
Rehabilitation of the Coronary Patient: A Preview of Tomorrow (1991) (16)
Dyslipidemia as a risk factor at elderly age. (2004) (16)
Is what's good for the gander good for the goose? (2003) (16)
Heart failure with preserved ejection fraction: Similarities and differences between women and men. (2020) (16)
Emerging clinical role of ranolazine in the management of angina (2010) (15)
Benefits of Exercise Training (1999) (15)
Research related to rehabilitation. (1979) (15)
Improved quality of life after PTCA: generalizability and concerns. (1992) (15)
Microvascular angina: an update on diagnosis and treatment. (2015) (15)
Call to Action for Cardiovascular Disease in Women: Epidemiology, Awareness, Access, and Delivery of Equitable Health Care: A Presidential Advisory From the American Heart Association. (2022) (15)
Ambulatory electrocardiographic recording (1981) (15)
Return to work after coronary bypass surgery and percutaneous transluminal angioplasty: issues and potential solutions. (1986) (15)
Risk Factor Modification after Myocardial Infarction (1989) (14)
Cardiovascular Disease: The Female Heart Is Vulnerable (2012) (14)
You've come a long way, baby (2018) (14)
Lipid Abnormalities in Women: Data for Risk, Data for Management* (2006) (14)
Atrial myxoma: overview, recognition, and management. (1987) (14)
Physical Activity and Exercise Training in the Elderly: A Position Paper from the Society of Geriatric Cardiology. (1998) (14)
Postmenopausal hormone use for cardioprotection: what we know and what we must learn. (1999) (14)
Cardiovascular disease in the elderly. (2011) (14)
Is cardiac rehabilitation necessary? (1992) (14)
Prevention of cardiovascular disease in women: highlights for the clinician of the 2011 American Heart Association Guidelines. (2013) (13)
Female‐friendly focus: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease (2019) (13)
Comparison of angiographic findings among postmenopausal women using unopposed estrogen, estrogen/progestin combinations, and nonusers. (2004) (13)
Peripartum cardiomyopathy: Status 2018 (2018) (13)
Cardiovascular effects of raloxifene: the potential for cardiovascular protection in women (2002) (13)
Cardiac rehabilitation : a guide to practice in the 21st century (1999) (13)
The greying of cardiology: implications for management (2007) (13)
Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease. (2012) (13)
Coronary bypass surgery as a rehabilitative procedure. (1982) (13)
Future Directions in Cardiovascular Rehabilitation (1987) (13)
Guidelines for the Reduction of Cardiovascular Disease in Women. (2016) (12)
Adverse Cardiovascular Outcomes for Women-Biology, Bias, or Both? (2020) (12)
Menopausal Hormone Therapy: a Comprehensive Review (2020) (12)
Response to Letter Regarding Article “Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in the Raloxifene Use for the Heart Trial: Results of Subgroup Analyses by Age and Other Factors” (2009) (12)
Emotional responses of patients with acute myocardial infarction to their disease. (1982) (12)
Angina in Women (2010) (12)
Harnessing Mobile Health Technology for Secondary Cardiovascular Disease Prevention in Older Adults: A Scientific Statement From the American Heart Association (2021) (12)
Strategies and Methods for Clinical Scientists to Study Sex-Specific Cardiovascular Health and Disease in Women. (2016) (12)
Rehabilitation of the coronary patient in 1989. (1989) (12)
Relationship Between Pregnancy Complications and Subsequent Coronary Artery Disease Assessed by Coronary Computed Tomographic Angiography in Black Women. (2019) (12)
Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the DEFINE‐HF trial (2021) (12)
Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study). (2016) (12)
Faculty Opinions recommendation of Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study. (2018) (11)
Juggling Multiple Guidelines: A Woman's Heart in the Balance. (2016) (11)
Representation of older adults in the late-breaking clinical trials American Heart Association 2011 Scientific Sessions. (2012) (11)
Cardiovascular disease in the elderly. (1987) (11)
Women in leadership positions in the medical academic enterprise: what are the next steps? (2008) (11)
Postmenopausal hormone therapy, SERMs, and coronary heart disease in women (1999) (11)
Sex and Race/Ethnicity Differences in Atrial Fibrillation. (2019) (11)
Heart disease in older women (2001) (11)
The comparative efficacy of ezetimibe added to atorvastatin 10 mg versus uptitration to atorvastatin 40 mg in subgroups of patients aged 65 to 74 years or greater than or equal to 75 years (2011) (11)
Diet and exercise for perimenopausal women lifestyle interventions can decrease cardiovascular risk. (2004) (10)
The Reynolds Risk Score: improved accuracy for cardiovascular risk prediction in women? (2007) (10)
Special Report Cardiovascular Disease in Women (1993) (10)
Should women have a different risk assessment from men for primary prevention of coronary heart disease? (1999) (10)
The early ambulation of patients after myocardial infarction. (1973) (10)
Diagnostic Cardiovascular Imaging and Therapeutic Strategies in Pregnancy: JACC Focus Seminar 4/5. (2021) (10)
Low Testosterone in Men with Cardiovascular Disease or Risk Factors: To Treat or Not To Treat? (2016) (10)
The Cardiovascular Trial of the Testosterone Trials: rationale, design, and baseline data of a clinical trial using computed tomographic imaging to assess the progression of coronary atherosclerosis (2016) (10)
Modern coronary rehabilitation. (1993) (10)
Preventive coronary interventions for women. (1996) (10)
Patient and family education after myocardial infarction. (1975) (10)
Left ventricular dysfunction, exercise capacity and activity recommendations. (1988) (10)
The feasibility of urokinase therapy in acute myocardial infarction. (1971) (10)
Women’s Health in Menopause (1994) (10)
Optimization of Drug Prescription and Medication Management in Older Adults with Cardiovascular Disease (2017) (10)
What Do the 2011 American Heart Association Guidelines Tell Us About Prevention of Cardiovascular Disease in Women? (2011) (10)
Evidence-based management of coronary artery disease in the elderly--current perspectives. (2005) (10)
Psychosocial Risk Factors Related to Ischemic Heart Disease in Women. (2016) (9)
Valvular heart disease in the elderly. (1986) (9)
Critical evaluation of cardiac rehabilitation. (1977) (9)
Cardiovascular drugs: the urgent need for studies in women. (1991) (9)
Guidelines for the prevention of cardiovascular disease in women: international challenges and opportunities (2012) (9)
Advancing Women's Heart Health through Policy and Science: Highlights from the First National Policy and Science Summit on Women's Cardiovascular Health. (2016) (9)
Menopausal hormone therapy: Currently no evidence for cardiac protection (2005) (9)
Rudimentary left coronary artery. (1961) (9)
Tailoring cardiovascular risk assessment and prevention for women: One size does not fit all (2017) (9)
Transforming Cardiovascular Disease Prevention in Women: Time for the Pygmalion Construct to End (2014) (9)
Special report: cardiovascular disease in women. Special writing group. (1994) (9)
VITAMIN D LEVELS ARE NOT RELATED TO MYALGIAS IN STATIN-TREATED PATIENTS WITH STABLE CORONARY DISEASE (2010) (9)
Demographic determinants of success in the vocational rehabilitation of cardiac patients. (1982) (8)
Assessment of quality of life: A medical imperative (2005) (8)
Cardiovascular health and disease in women: coronary heart disease in women: an overview (myths, misperceptions, and missed opportunities) (1993) (8)
Education of the patient with cardiac disease in the twenty-first century: an overview. (1986) (8)
Electrocardiograms of menopausal women with coronary heart disease or at increased risk for its occurrence. (2010) (8)
Effect of Preload Reduction by Hemodialysis on Left Atrial Volume and Echocardiographic Doppler Parameters in Patients With End-Stage Renal Disease (2004) (8)
Cardiovascular Disease in the Octogenarian and Beyond (1998) (8)
A preliminary study of the electrocardiogram of the normal premature infant. (1961) (8)
Adherence to screening guidelines for breast and cervical cancer in postmenopausal women with coronary heart disease: an ancillary study of volunteers for hers. (2001) (8)
Coronary heart disease in women: clinical syndromes, prognosis, and diagnostic testing. (1989) (8)
Cardiovascular disease in the elderly. Heart failure. (1987) (8)
Postmenopausal hormone-replacement therapy. (2002) (8)
Symposium: the use of physical activity in the rehabilitation of patients after myocardial infarction. (1970) (8)
Coronary disease in elderly patients: myocardial infarction and myocardial revascularization. (1994) (8)
Cardiac rehabilitation in women, challenges and opportunities. (2022) (8)
Preventing coronary heart disease in women (2002) (8)
Non-ST elevation acute coronary syndrome in women and the elderly: recent updates and stones still left unturned (2018) (8)
Hypertension management in older adults (2020) (8)
Hyperlipidemia versus iron overload and coronary artery disease: yet more arguments on the cholesterol debate. (1996) (8)
[Menopausal hormone therapy and cardiovascular disease]. (2006) (8)
Preventive cardiology in the elderly. (1997) (8)
Women and Heart Disease (2005) (7)
Cardiac Rehabilitation : Guide to Procedures for the Twenty-first Century (1999) (7)
Drug choice affects treatment compliance and blood pressure outcomes in elderly hypertensive patients. (2007) (7)
Rehabilitation of the coronary artery disease patient: capturing patients. (1997) (7)
1099-87 Symptoms persist in patients with chronic angina despite frequent anti-anginal use and prior revascularization (2004) (7)
Cardiovascular risk factors, cardiovascular disease, cardiovascular drug therapies, and dementia/cognitive dysfunction: how do the pieces of the puzzle fit together? (2007) (7)
Are we there yet? Closing the gender gap in coronary heart disease recognition, management and outcomes (2013) (7)
Prevention of Cardiovascular Disease in Older Adults (2014) (7)
Patient and Family Education and Counseling: A Requisite Component of Cardiac Rehabilitation (1982) (7)
SMARTWOMAN™: Feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women (2019) (7)
Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs. A statement for healthcare professionals from the American Association for Cardiovascular and Pulmonary Rehabilitation and the American Heart Association. (2005) (7)
Ranolazine Reduces Angina in Women with Ischemic Heart Disease: Results of an Open-Label, Multicenter Trial. (2019) (7)
Quality of life in chronic cardiovascular illness. (1992) (7)
Resting electrocardiogram predicts mortality in postmenopausal women with coronary heart disease or with risk factors for coronary heart disease (2014) (7)
Gender Disparities in Cardiac Rehabilitation Among Older Women: Key Opportunities to Improve Care. (2019) (7)
Radiographic identification of commonly used implanted pacemakers. (1969) (7)
Women, myocardial infarction, and coronary revascularization: concordant and discordant clinical trial and registry data. (1999) (7)
Rationale and design of a smartphone‐enabled, home‐based exercise program in patients with symptomatic peripheral arterial disease: The smart step randomized trial (2020) (7)
18th Bethesda conference: Cardiovascular disease in the elderly* (1987) (6)
A Naturally Randomized Trial Comparing the Effect of Long ‐ term Exposure to Low LDL ‐ C , Low SBP , or Both on the Risk of Cardiovascular Disease (2017) (6)
A 50-year-old useful report on coronary risk for noncardiac surgery. (1990) (6)
Heightened Cardiovascular Risk in Diabetic Women: Can the Tide Be Turned? (2007) (6)
Hormonal and Nonhormonal Therapies for the Postmenopausal Woman: What is the Evidence for Cardioprotection? (2000) (6)
VKORC1-1639A allele influences warfarin maintenance dosage among Blacks receiving warfarin anticoagulation: a retrospective cohort study. (2018) (6)
Rheumatic fever without clinical evidence of carditis. (1966) (6)
An educational algorithm for myocardial infarction. (1974) (6)
A Statement on Ethics from the HEART Group (2008) (6)
The ECG in normal pregnancy. (1982) (6)
Coronary Heart Disease in Men and Women: Does 1 Size Fit All? No! (2011) (6)
Why community physicians should encourage their patients to participate in randomized clinical trials. (1978) (6)
Hormone treatment--misconceptions and agreements. (2002) (6)
From adrenoceptor mechanisms to clinical therapeutics: Raymond Ahlquist, Ph.D., 1914-1983. (1984) (6)
C-reactive protein and coronary heart disease. (2004) (6)
Coronary heart disease in women: battle is won, but the war remains. (2007) (6)
VITAMIN D LEVELS DO NOT PREDICT CARDIOVASCULAR EVENTS IN STATIN-TREATED PATIENTS WITH STABLE CORONARY DISEASE (2010) (6)
Do We Need a Different Approach to Assess Cardiovascular Risk in Women (2016) (6)
Cardiovascular care for women: the 10-Q Report and beyond. (2013) (6)
Coronary risk reduction in the menopausal woman. (1999) (6)
The Risk of Remaining Silent: Addressing the Current Threats to Women's Health. (2017) (6)
Baseline characteristics of menopausal women with coronary heart disease in cardiovascular outcomes clinical trials of menopausal hormone therapy or raloxifene. (2005) (5)
Addressing coronary heart disease risk in women. (1998) (5)
A statement on ethics from the HEART Group (2009) (5)
Uncertainty in medicine: still very much with us in 2004. (2004) (5)
Coumarin Resistance: A Diagnostic and Therapeutic Approach (1977) (5)
Biomarkers and Non-Calcified Coronary Artery Plaque Progression in Older Men Treated with Testosterone. (2019) (5)
Ambulatory ECG recording. Part II. (1980) (5)
[II Guidelines of Brazilian Society of Cardiology in geriatric cardiology]. (2010) (5)
Social support and coronary heart disease in women: the challenge to learn more. (1998) (5)
Lifestyle Interventions to Improve Exercise Tolerance in Obese Older Patients With Heart Failure and Preserved Ejection Fraction. (2016) (5)
The physiologic basis for early ambulation after myocardial infarction. (1978) (5)
Disparities in ST-elevation myocardial infarction management for the young goose and young gander: clinical, organizational, and educational challenges. (2015) (5)
Mercury in the heart. (1991) (5)
Patient-centered care in geriatric cardiology. (2021) (5)
Specific heart muscle diseases (1985) (5)
Absence of bacteremia after diagnostic biopsy of the cervix: chemoprophylactic implications. (1974) (5)
Questions on the validity of papers on mitral valve prolapse and on cardiomyopathy. (1983) (5)
Psychosis. A probable result of propranolol therapy. (1979) (5)
Atrial Fibrillation at Elderly Age: The Importance of Stroke Prevention. (1997) (5)
Recognition and prevention of cardiovascular disease in women (2005) (5)
Lipid metabolism, physical activity, and postmenopausal hormone therapy. (1998) (5)
Cardiac Rehabilitation for Women (2013) (5)
Engaging Families in Adult Cardiovascular Care: A Scientific Statement From the American Heart Association (2022) (5)
Cardiovascular Disease in Women: Understanding the Journey. (2021) (5)
Rehabilitation after myocardial infarction. (1979) (5)
Women and Heart Disease: Highlights for Clinical Practice (2006) (4)
Coronary heart disease in women: 1996. (1996) (4)
Exercise testing and training of the elderly coronary patient. (1992) (4)
Pathophysiology and Lifetime Risk Factors for Atherosclerosis and Coronary Artery Disease in Women and in the Elderly (2015) (4)
Exercise and elderly persons. (2001) (4)
Coronary Heart Disease in Women (2009) (4)
Oral anticoagulant therapy--an algorithm to facilitate control. (1996) (4)
Menopausal hormone therapy: Is there evidence for cardiac protection? (2004) (4)
Modern coronary rehabilitation. New concepts in care. (1993) (4)
Exercise and the heart. (1987) (4)
The Editor's Roundtable: The 10Q Report - Advancing women's heart health through improved research, diagnosis, and treatment. (2013) (4)
Early Mobilization After Myocardial Infarction: Historical Perspective and Critical Appraisal (1980) (4)
TRENDS IN ACUTE POST-ABLATION PERICARDITIS AND RELATED HEALTHCARE BURDEN IN SYMPTOMATIC ATRIAL FIBRILLATION HOSPITALIZATIONS: INSIGHTS FROM THE NATIONAL INPATIENT SAMPLE (2009-2014) (2019) (4)
Opiate inhibition of sheep erythrocyte binding to T lymphocytes: reversal by naloxone and cyclic nucleotides. (1981) (4)
Infectious myocarditis. (1968) (4)
Menopausal hormone therapy and cardiovascular protection: state of the data 2003. (2003) (4)
Gender differences in acute coronary syndromes: focus on the women with ACS without an obstructing culprit lesion (2018) (4)
Geriatric Cardiology: Coming of Age (2022) (4)
Drugs for Cardiovascular Disease Prevention in Women (2012) (4)
Lewis Dexter, MD 1910–1995 (1996) (3)
The elderly and cardiovascular disease: some differences, but many similarities to their younger counterparts. (2004) (3)
Cardiac rehabilitation services in the U.S. (1989) (3)
Spontaneous decompression of portal hypertension. (1962) (3)
A focus on heart failure and other age-related cardiovascular conditions. (2005) (3)
The Coronary Drug Project: implications for clinical care. (1977) (3)
Sustained-release procainamide and neutropenia. (1984) (3)
What's New in Antiplatelet and Anticoagulant Therapy Recommendations for Unstable Angina/Non–ST‐Elevation Myocardial Infarction (2012) (3)
Evidence-based management of acute myocardial infarction in the elderly--current perspectives. (2005) (3)
Surgical coronary revascularization in the elderly. (2002) (3)
Long-term management of patients following successful percutaneous transluminal coronary angioplasty and coronary artery bypass grafting. (1986) (3)
Managing Ambulatory Anticoagulation (2001) (3)
Response to exercise in patients taking psychotropic drugs. Arrhythmias and the QT interval (QT wave peak). (1982) (3)
Exercise prescription. (1981) (3)
Anticoagulation at elderly age: the challenge to do better. (2003) (3)
The changing pattern of coronary heart disease in the elderly. (2002) (3)
Menopausal Hormone Therapy for Cardiovascular Protection—Unfulfilled Expectations (2009) (3)
Early ambulation physical activity: myocardial infarction and coronary artery bypass surgery. (1984) (3)
Management Options in Chronic Stable Angina Pectoris: Focus on Ranolazine (2009) (3)
Coronary Heart Disease in Women: Evolution of Our Knowledge (2015) (3)
Exercise stress testing: an overview, 1979. (1980) (3)
Exercise for the Elderly: Highlights of Preventive and Therapeutic Aspects (1989) (3)
Hypertension and other cardiovascular risks in women (1995) (3)
Oral Anticoagulant Therapy at Elderly Age: Heart Failure and Nonvalvular Atrial Fibrillation. (1996) (3)
Rheumatic fever without clinical evidence of carditis: the necessity and efficacy of chemoprophylaxis. (1966) (3)
The role of exercise in the primary and secondary prevention of coronary atherosclerotic heart disease. (1990) (3)
Not for Students Only (1994) (3)
[The current state of hormonal prevention of coronary heart disease in menopausal women]. (2003) (3)
Early ambulation after myocardial infarction. The in-patient exercise program. (1984) (3)
Cardiac problems of the adolescent and young adult (1985) (3)
Noninvasive Testing in Women With Suspected Ischemic Heart Disease: Ten Highlights to Guide Quality Clinical Care (2014) (3)
Evolving cardiovascular care for women: a decade of progress. (2015) (2)
Do We Need an Apgar Score for Older Adults? (2019) (2)
Do Diet, Folic Acid, and Vitamins Matter?: What Did We Learn From The Women's Health Initiative, The Women's Health Study, The Women's Antioxidant and Folic Acid Cardiovascular Study, and Other Clinical Trials? (2007) (2)
Benefits of a rehabilitation program following myocardial infarction. (1973) (2)
Cardiac Rehabilitation and Risk Reduction (2015) (2)
The elderly patient with coronary heart disease: Contemporary practices and future challenges (1994) (2)
Diagnostic testing for coronary heart disease in women: new information generates new questions. (1999) (2)
Erratum : The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men (Clinical Trials (2014) 11 (362-375) DOI: 10.1177/1740774514524032) (2015) (2)
The Feminine Face of Ischemic Heart Disease: Challenges and Opportunities. (2019) (2)
Rehabilitation after myocardial infarction. (1985) (2)
Is It Useful for Coronary Prevention (1998) (2)
Can We Avert an Acute Coronary Syndrome? Unmet Public and Professional Education/Information Needs (2018) (2)
Coronary Revascularization in Women (2005) (2)
Treating dyslipidemia in the elderly (2006) (2)
Coronary heart disease: a substantial threat to women. (1997) (2)
Guidelines for dietary management after myocardial infarction. (1979) (2)
Women's heart health: a worldwide challenge. (2011) (2)
Who should be treated with implantable cardioverter-defibrillators? (2006) (2)
Cardiovascular disease in the elderly. (1988) (2)
Symposium: gender differences in cardiac imaging. (1996) (2)
Abstract twenty-first annual scientific session American college of cardiologyMassive acute pulmonary embolism—Deceivingly nonspecific manifestations☆ (1972) (2)
Toward optimal health: advances in the cardiovascular care of women. [An interview with Jodi R. Godfrey and Wenger K. Nanette]. (2010) (2)
Women Physicians: Burnout during the COVID-19 Pandemic in Brazil. (2022) (2)
Abstract 3731: Intensive Lipid Lowering with Atorvastatin is Associated with Significant Cardiovascular Benefits in Patients with and without Chronic Kidney Disease: The Treating to New Targets (TNT) Study (2006) (2)
The Clinical Spectrum of Myocardial Infarction and Ischemia With Nonobstructive Coronary Arteries in Women. (2020) (2)
Perspective: A heartfelt plea (2017) (2)
Is There a Role for Menopausal Hormone Therapy (MHT) for Cardiovascular Disease Prevention in Select Postmenopausal Women? (2013) (2)
Dx and Tx of the elderly patient with atherosclerotic coronary heart disease. (1985) (2)
Approaching cardiac arrhythmias in the elderly patient. (2005) (2)
For the patient. What is the Metabolic Syndrome and why is it important? (2003) (2)
Unstable Angina/Non‐ST‐Elevation Myocardial Infarction (2009) (2)
HT and CVD prevention. from myth to reality. (2003) (2)
What if the FDA had launched its action plan to close the health disparities gap for women two decades earlier? (2015) (2)
Cardiac rehabilitation as secondary prevention: Quick reference guide for clinicians (1996) (2)
The future of rehabilitation: a component of routine cardiac care. (1978) (2)
Underserved populations: challenge for the new millennium. (2001) (2)
Charles K. Friedberg (1986) (2)
The use of exercise in the rehabilitation of patients after myocardial infarction. (1969) (2)
in Asymptomatic Adults (2010) (2)
Essentials of cardiovascular care for older adults: extending a US-based educational resource for collaboration with our China colleagues (2015) (2)
Coronary Heart Disease at Elderly Age: Determinants of Clinical Decision-Making. (1995) (2)
Insights From the Cardiovascular Health Study in Older Adults and From Other (2004) (2)
SULFADIAZINE PROPHYLAXIS AGAINST RHEUMATIC FEVER DURING PREGNANCY: ITS SAFETY AS REGARDS THE INFANT. (1965) (2)
Chest Pain With Normal Coronary Arteries (1985) (2)
Selected cardiac problems in the elderly patient. (1979) (2)
Lipid management and control of other coronary risk factors in the postmenopausal woman. (2000) (2)
Review of the 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: What is New and Why? (2016) (2)
Special Considerations in the Prevention of Cardiovascular Disease in Women. (2022) (2)
Women and cardiovascular diseases in Latin America and the Caribbean: A recommendation for health professionals from the InterAmerican Heart Foundation (2000) (2)
Drugs for cardiovascular disease prevention in women: implications of the AHA Guidelines--2007 Update. (2008) (2)
Rehabilitation of the coronary patient. (1972) (2)
Uncomplicated acute myocardial infarction: long-term management. (1983) (2)
Effect of coronary heart disease (CHD) risk factors and medications on invasive breast cancer risk in the Raloxifene Use for The Heart (RUTH) trial (2007) (2)
Quality of life: Why the burgeoning interest in the clinical and research cardiology communities? (1992) (2)
Depression and Anxiety in Women with Heart Disease (2016) (2)
Menopausal Hormone Therapy (2004) (2)
Rehabilitation of the patient after myocardial infarction: the pivotal role of the primary care physician. (1977) (2)
Return to Work after Coronary Bypass Surgery: Problems and Prospects (1985) (2)
Book Reviews : Cardiovascular Disease in the Octogenarian and Beyond (1999) (2)
Coronary heart disease in women. The high prevalance of coronary risk factors and the importance of prevention. (1995) (2)
CHAPTER 38 – Special Patient Populations: Women and Elderly (2009) (2)
Mutations in the Genes Regulating Methylene Tetrahydrofolate Reductase (MTHFR C!T677) and Cystathione b b-Synthase (CBS G!A919, CBS T!c833) Are Not Associated with Myocardial Infarction in (2001) (2)
Cardiovascular Disease inWomen (1999) (2)
Rehabilitation of elderly coronary patients. (1986) (2)
Cardiovascular Disease Prevention in Women (2009) (1)
Asymptomatic Adults: Executive Summary 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in (2010) (1)
Geriatric cardiology and the Great Wall International Congress of Cardiology 2015 (2016) (1)
Congratulations! the american journal of geriatric cardiology has been accepted for indexing in index medicus! (2001) (1)
Hippocrates, Maimonides, and End-of-Life Issues. (2004) (1)
Assessing and addressing risk of cardiovascular disease in perimenopausal and early postmenopausal women. (2010) (1)
America vs Europe and the 2014 Non-ST Elevation Acute Coronary Syndrome Guidelines (2015) (1)
Pulmonary embolism and the urokinase pulmonary embolism trial. (1970) (1)
Coronary Heart Disease in Postmenopausal Women: What We Know and What We Must Learn (1994) (1)
Observational studies can help fill important gaps in understanding and treating cardiovascular disease in the elderly. (2007) (1)
Abstract 20653: Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort of Women: The Women’s Health Initiative (2017) (1)
Guidelines of the Cardiogeriatrics Department of the Brazilian Cardiology Society: commentary by Editorial Board Members of The American Journal of Geriatric Cardiology. (2004) (1)
Effect of pharmacological agents on exercise testing and exercise training of the coronary patient. (1983) (1)
The case of the incorrect magnet. (1988) (1)
Abstract 848: Improvement in Estimated Glomerular Filtration Rate With Atorvastatin in Patients With Metabolic Syndrome: The Treating to New Targets Study (2009) (1)
Evidence‐Based Medicine, Systems‐Based Practice, and This Issue of The American Journal of Geriatric Cardiology (2006) (1)
Cardiac pacemaker therapy at Grady Memorial Hospital, 1964-1978 (with patient follow up through 1980). (1982) (1)
Rehabilitation After Myocardial Infarction: Prognostic Features and Psychosocial Considerations (1985) (1)
Guidelines for Exercise Training of Elderly Patients With Coronary Artery Disease (1994) (1)
Hypertension and quality of life issues. (1989) (1)
Rehabilitation of the patient with myocardial infarction. Responsibility of the primary care physician. (1981) (1)
[Management of patients with uncomplicated myocardial infarction - changes in the past decade]. (1982) (1)
Pseudo anterior myocardial infarction as a manifestation of severe pulmonary embolism. (1981) (1)
Diagnostic Value of Ambulatory Electrocardiography: Dependence on Presenting Symptom, Age and Sex (1988) (1)
Arrhythmia-induced cerebral ischemia. (1970) (1)
Hormonal and nonhormonal approaches for cardioprotection (1999) (1)
Women & Heart Disease (1997) (1)
The geriatric paradox. (2008) (1)
Science and the practice of cardiovascular medicine in the geriatric population (2011) (1)
Efficacy, tolerance, and safety of colestipol HCL as a hypocholesterolemic agent in hyperlipidemic patients with studies of its effect on gastrointestinal absorption. (1981) (1)
Introduction: Coronary Care. (1975) (1)
Hypertension Control at Elderly Age-We Can and Should Do Better. (2000) (1)
Acute coronary syndromes thrombolysis, angioplasty (2005) (1)
Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years (2014) (1)
Residual risk in TNT (2012) (1)
Women, their age, and their cholesterol values. (2008) (1)
Recent Legislation, Public Policy Changes, and Women's Cardiovascular Health. (2018) (1)
Top 10 List for the Cardiovascular Care of Older Adults. (2016) (1)
The United States, Britain and New Zealand--coronary artery disease is an equal opportunity killer. (1994) (1)
Preventive cardiology--its applicability at elderly age. (2001) (1)
Guest Editorial Women's Heart Research: It's About Time (1995) (1)
A cardiologist's view of hormone replacement therapy and alternatives for cardioprotection. (2001) (1)
Faculty Opinions recommendation of A decade of changes in clinical characteristics and management of elderly patients with non-ST elevation myocardial infarction admitted in Italian cardiac care units. (2017) (1)
Aging in the americas: Its impact on cardiovascular health (1992) (1)
MYOCARDIAL INFARCTION SYMPTOM PRESENTATION AND HOSPITAL MORTALITY: RELATIONSHIP TO AGE AND SEX IN THE NATIONAL REGISTRY OF MYOCARDIAL INFARCTION (NRMI) (2010) (1)
Problems in management of the pregnant patient with rheumatic heart disease and valve prosthesis. (1976) (1)
Evaluation of methyclothiazide therapy for angina pectoris. (1963) (1)
Efficacy and Safety of Fenofibric Acid and Rosuvastatin Combination Therapy in Women 55 Years or Older (Post-Menopausal) with Mixed Dyslipidemia (2009) (1)
Secondary Prevention of Cardiovascular Disease in the Very Old—A Good Idea Whose Time Has Come (2005) (1)
Management of the patient with myocardial infarction. (1979) (1)
Thrombotic occlusion of a Bjork-Shiley mitral valve. (1986) (1)
Acute rheumatic fever without carditis: A reappraisal (1966) (1)
Three causes of syncope of one patient, detected by Holter monitoring. (1977) (1)
Physical Activity, and Metabolism and the Council on Clinical Cardiology Scientific Statement From the American Heart Association Council on Nutrition, Exercise and Acute Cardiovascular Events: Placing the Risks Into Perspective: A (2007) (1)
Gender Differences in Coronary Risk Factors and Risk Interventions (2011) (1)
PROGNOSTIC MODEL OF RESIDUAL RISK FOR MAJOR CARDIOVASCULAR EVENTS IN STATIN-TREATED CORONARY PATIENTS: A COMBINED ANALYSIS OF THE IDEAL AND TNT TRIALS (2012) (1)
Update : Systemic Diseases and the Cardiovascular System ( VII ) Cardiovascular Disease in the Elderly (2017) (1)
Clinical trial evidence for women’s cardiovascular health: what we know and what we must learn (2005) (1)
Abstract 2181: Risk of Stroke in the Raloxifene Use for The Heart (RUTH) Trial (2006) (1)
Evidence-Based Guidelines for Cardiovascula r Disease Prevention in Women: 2007 Updat e (2007) (1)
Treatment of the elderly patient with cardiovascular disease—The challenge to do better (1996) (1)
Fluorescent treponemal antibody-absorption (FTA-ABS) test in patients with aortic valvular insufficiency. (1970) (1)
Arthur M. Master, 1895–1973 (1988) (1)
Effects of Ezetimibe Added to Atorvastatin Versus Atorvastatin Up-Titration on Attainment of Single and Dual Levels for Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol, Apolipoprotein B, or High-Sensitivity C-Reactive Protein in Older Adults with High Coronary Heart (2010) (1)
Pathophysiology and Management of Myocardial Infarction (2015) (1)
Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: Unfulfilled Expectations. (2017) (1)
THE RELATIONSHIP BETWEEN POLYMORPHISM IN THE ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE GENE AND ISCHEMIC STROKE IN A JAPANESE POPULATION (1998) (1)
Erratum: Prediction of cardiovascular events in statin-treated patients by lipid and non-lipid biomarkers (Journal of the American College of Cardiology (2011) 57 (63-69)) (2013) (1)
PO16-439 COST-EFFECTIVENESS OF INTENSIVE LIPID-LOWERING TREATMENT IN SECONDARY CARDIOVASCULAR PREVENTION IN SPAIN AND GERMANY (2007) (1)
Carotid sinus syncope. (1976) (1)
Supervised versus unsupervised exercise training following myocardial infarction and myocardial revascularisation procedures. (1992) (1)
Hormone therapy not recommended for chronic disease prevention in menopausal women (2012) (1)
Rehabilitation of the elderly cardiac patient. (1981) (1)
High Risk, High Stakes: Optimizing Cardiovascular Risk Assessment in Women (2012) (1)
Gender differences in cardiovascular risk: a varying variable. (2011) (1)
Multivitamins in the prevention of cancer and cardiovascular disease: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial (2022) (1)
Cardiac rehabilitation: the United Kingdom and the United States. (1976) (1)
Hypertension at elderly age: what we know and what we must learn. (2002) (1)
A Statement on Ethics from the HEART Group (2008) (1)
Usefulness of lipid-lowering therapy in elderly patients. (2002) (1)
Exploring sex/gender differences in women's cardiovascular health. (2007) (1)
Rehabilitation of the Elderly Cardiac Patient: Recommendations of the Clinical Practice Guideline Cardiac Rehabilitation. (1996) (1)
Pulmonary embolism. Strategy for evaluation and treatment of patients at increased risk. (1988) (1)
Accountability and transparency in medical publishing: position and policies of le jacq on authorship, acknowledgments, conflicts of interest, and secondary and redundant publication. (2008) (1)
Ambulatory ECG recording. Part I. (1980) (1)
Mentoring women physicians. (2001) (1)
Summary of the Discussion (1985) (1)
A study of the oral flora in children receiving sulfadiazine prophylaxis against rheumatic fever. (1966) (1)
Valvular heart disease at elderly age: new vistas. (2006) (1)
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women Expert Panel / Writing Group * (2004) (1)
Session III: Current Status of Electrical Control of Tachyarrhythmias (1984) (1)
Faculty Opinions recommendation of Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane Systematic Review and Meta-Analysis. (2018) (1)
Cardiac inpatient conditioning program. (1969) (1)
The Ten Most Commonly Asked Questions about Coronary Heart Disease in Women (1998) (1)
Faculty Opinions recommendation of Edoxaban versus warfarin in patients with atrial fibrillation. (2016) (0)
WHAT IS THE METABOLIC SYNDROME AND WHY IS IT IMPORTANT (2003) (0)
Cardiovascular Research in the Elderly. (2000) (0)
Coronary risk attributes, coronary risk reduction, and clinical outcomes. (2006) (0)
A spectrum of clinical issues in geriatric cardiology. (2003) (0)
Faculty Opinions recommendation of Sex differences in cardiovascular disease - Impact on care and outcomes. (2018) (0)
Subacute bacterial endocarditis associated with an ostium primum defect and congenital anomalies of the mitral and aortic valves. (1962) (0)
Myocarditis: unresolved diagnostic and therapeutic issues (1989) (0)
Postmenopausal hormone replacement [2] (multiple letters) (1998) (0)
Common cardiac conditions in the elderly are still not well understood. (2004) (0)
Prescription Drugs for Elderly Patients and Medicare Reform. (1999) (0)
K/doqi Tm Disclaimer K/doqi Advisory Board Members K/doqi Tm Nutrition Work Group Membership Adult Work Group Members Pediatric Work Group Members Nkf-doqi Advisory Council* Nkf-doqi Steering Committee* Acronyms and Abbreviations List Abbreviation Term A1-ag A1-acid Glycoprotein Abw Ef Adjusted Edem (0)
Patient selection, statistical presumption, and uncertainty of outcomes. (2007) (0)
Faculty of 1000 evaluation for Primary prevention of cardiovascular disease with a Mediterranean diet. (2016) (0)
Management of heart failure in the elderly: still much to be learned. (2007) (0)
Fluorescent Treponemal Antibody Absorption (1970) (0)
Use of exercise testing in noncoronary heart disease. (1985) (0)
Faculty Opinions recommendation of Sex Differences in the Presentation and Perception of Symptoms Among Young Patients With Myocardial Infarction: Evidence from the VIRGO Study (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients). (2018) (0)
Acute Coronary Syndromes in the Elderly [version 1; peer review: 3 approved] (2019) (0)
Faculty Opinions recommendation of Magnitude of hypotension based on office and ambulatory blood pressure monitoring: results from a cohort of 5066 treated hypertensive patients aged 80 years and older. (2020) (0)
In memoriam: Herman K. Hellerstein, MD--physician, scientist, scholar, teacher and friend. (1994) (0)
Faculty Opinions recommendation of LDL cholesterol reduction in elderly patients with the PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of 1779 patients in phase 2, 3 and open label extension studies. (2016) (0)
Evidence of left ventricular dysfunction as judged from the routine clinical assessment. (1986) (0)
Cardiovascular Disease in the Elderly (1993) (0)
Faculty Opinions recommendation of An Invasive vs a Conservative Approach in Elderly Patients with Non-ST-Segment Elevation Myocardial Infarction: Systematic Review and Meta-Analysis. (2018) (0)
56 Withdrawn Effects of intensive lipid lowering with atorvastatin on congestive heart failure: subgroup analysis of the Treating to New Targets (TNT) study (2006) (0)
ECG telemetry and ambulatory ECG: role in cardiac rehabilitation (1989) (0)
Optimal Cardiac Care at Elderly Age: A Contemporary Challenge. (1999) (0)
Patients by Lipid and Nonlipid Biomarkers Prediction of Cardiovascular Events in Statin-Treated Stable Coronary (2012) (0)
Improved Cardiovascular Disease Outcomes in Older Adults (version 1; referees: 3 approved) (2016) (0)
Faculty Opinions recommendation of Factors associated with non-participation in and dropout from cardiac rehabilitation programmes: a systematic review of prospective cohort studies. (2018) (0)
Physical Activity and Public Health 6-24-2003 Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease : A Statement (2019) (0)
Exercise and rehabilitation in elderly cardiac patients (1993) (0)
Drugs in the Primary and Secondary Prevention of Coronary Artery Disease (2015) (0)
SEX DIFFERENCES IN PRESENTATION WITHOUT CHEST PAIN FOR CONFIRMED MYOCARDIAL INFARCTION ARE ATTENUATED WITH ADVANCING AGE IN THE NATIONAL REGISTRY OF MYOCARDIAL INFARCTION (NRMI) (2010) (0)
Long-Term Results of Coronary Rehabilitation: Rationale, Implementation and Significance of Programs (1984) (0)
Faculty Opinions recommendation of ACC/AHA versus ESC/ESH on hypertension guidelines: JACC guideline comparison. (2020) (0)
Abstract 2750: Prehypertension and Cardiovascular Risk in the Women's Health Initiative (2006) (0)
Postmenopausal Hormone Replacement (1998) (0)
Treatment of Hyperlipidemia in Women (1996) (0)
Principles of Primary and Secondary Prevention of Cardiovascular Disease (2015) (0)
Introductory remarks. III (1987) (0)
Lessons from the decline in coronary atherosclerotic heart disease mortality in the USA. (1983) (0)
CARDIOVASCULAR DISEASE IN POSTMENOPAUSAL WOMEN — (2002) (0)
Cardiovascular Therapies at Elderly Age: New Questions, New Answers. (2000) (0)
Abstract P152: Differences in Symptom Presentation According to Type of Acute Myocardial Infarction (2011) (0)
Acute coronary artery disease in the elderly: less ventured, less gained. (2006) (0)
Faculty Opinions recommendation of 2017 acc/aha/aapa/abc/acpm/ags/apha/ash/aspc/nma/pcna guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the american college of cardiology/american heart association task force on clinical practice gui (2020) (0)
Faculty of 1000 evaluation for Transcatheter valve therapy: a professional society overview from the American College of Cardiology Foundation and the Society of Thoracic Surgeons. (2016) (0)
Exercise Testing and Training of Patients with Congestive Heart Failure and Left Ventricular Dysfunction (1991) (0)
Investigation—Not Extrapolation (2005) (0)
Faculty Opinions recommendation of Effect of intensive vs standard blood pressure control on probable dementia: A randomized clinical trial. (2020) (0)
Rehabilitation following coronary artery bypass graft surgery at elderly age (1995) (0)
about the evolving management of coronary heart disease in older adults ? (0)
Cardiovascular Pharmacotherapy at Elderly Age. (2000) (0)
Sex Differences in Subclinical Coronary Atherosclerosis in Psoriasis by Coronary Computed Tomography Angiography. (2021) (0)
Faculty Opinions recommendation of Transcatheter versus surgical aortic-valve replacement in high-risk patients. (2016) (0)
PO23-733 INTENSIVE ATORVASTATIN THERAPY IS ASSOCIATED WITH SIGNIFICANT CARDIOVASCULAR BENEFITS IN PATIENTS WITH AND WITHOUT CHRONIC KIDNEY DISEASE: THE TNT STUDY (2007) (0)
IS CARDIAC REHABILITATION NECESSARY ? AUTHOR'S REPLY (1992) (0)
Redefining the Roles of Aspirin Across the Spectrum of Cardiovascular Disease Prevention. (2023) (0)
agement of coronary heart disease in older adults ? (2013) (0)
1135-67 Time trends in the treatment of women and men with acute myocardial infarction in the United States (2004) (0)
Critical evaluation of cardiac rehabilitation. Conference summary. (1976) (0)
Reply to: Statins for Primary Prevention in Older Adults (2019) (0)
Progress in treating hypertension. (2008) (0)
Coronary Heart Disease in Women, a Decade of Changing Concepts: Approaches to Diagnostic Evaluation and Preventive Therapy (1998) (0)
Analyzing the Results of the Treating to New Targets Study (2008) (0)
Faculty Opinions recommendation of Cardiac rehabilitation for women: A systematic review of barriers and solutions. (2018) (0)
10 Risk Factors and the Prevention of Heart Disease (2003) (0)
Efficacy of Ezetimibe Added to Atorvastatin vs Uptitration of Atorvastatin in the Elderly (2009) (0)
Cardiac Rehabilitation: United States (2007) (0)
10th Anniversary of The American Journal of Geriatric Cardiology and the New Millenium (2001) (0)
Does exercise training enhance collateral circulation? (1976) (0)
on Physical Activity) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) Atherosclerotic Cardiovascular Disease: A Statement From the Council on Exercise and Physical Activity in the Prevention (2007) (0)
Is strenuous physical activity appropriate for patients with coronary heart disease? (1982) (0)
Geriatric Cardiology Benefits From Both Steps Forward and Looks Backward (2005) (0)
Stephen Scheidt, MD (2007) (0)
Include the Elderly in Cardiovascular Trials (2006) (0)
Effect of High-Dose Atorvastatin on Hospitalizations for Heart Failure Subgroup Analysis of the Treating to New Targets (TNT) Study Heart Failure (2007) (0)
The Changing Demography of Coronary Disease and Its Therapy—a Continuing Quest for Answers (2001) (0)
HDL and Triglycerides in the Year 2011: What Might the NCEP ATP IV Guidelines Look Like? (2016) (0)
Women’s Health and Menopause (1999) (0)
Women leaders: transforming the culture in cardiology (2022) (0)
Pulmonary embolism. (1975) (0)
A Statement on Ethics from the HEART Group (2010) (0)
Incremental Change versus Disruptive Transformation: COVID-19 and the Cardiovascular Community. (2021) (0)
Drug therapy in the elderly. (2003) (0)
The Need for Continuing Education in Geriatric Cardiology. (2000) (0)
The Expanding Role of Echocardiography (2000) (0)
Cardiac rehabilitation: edited by Lenore R. Zohman, MD and Jerome S. Tobis, MD. New York, Grune & Stratton, 1970, 248 pages, $12.75 (1972) (0)
Faculty Opinions recommendation of 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the american college of cardiology/american heart association task force on clinical practice guidelines. (2018) (0)
Rheumatic fever without clinical evidence of carditis: a reappraisal. (1966) (0)
Prescription Drugs For The Elderly: How Physicians Can Help. (1999) (0)
Living Not Only Longer, But Better. (1997) (0)
Improved Cardiovascular Disease Outcomes in Older Adults [version 1; peer review: 3 approved] (2020) (0)
Subject Index, Vol. 65, 1980 (1980) (0)
Cyanotic congenital heart disease in an adult. (1977) (0)
The X-Factor: Global Impact of Women in the Awareness and Management of Coronary Artery Disease (2015) (0)
SEX-SPECIFIC DISPARITIES IN PATIENTS UNDERGOING ISOLATED CABG (2023) (0)
Clinical-pathological correlations at the "Old Gradys". (2000) (0)
Faculty of 1000 evaluation for 'Hearts and minds': association, causation and implication of cognitive impairment in heart failure. (2016) (0)
Faculty Opinions recommendation of Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial. (2016) (0)
Cardiac Imaging in Elderly Patients. (1999) (0)
Circulation: Cardiovascular Quality and Outcomes (2021) (0)
Therapeutic physical activity programs for patients with myocardial infarction. (1973) (0)
Heart Disease in the Elderly: A Joint Symposium - Co-Sponsored by the Japan Geriatrics Society and the Council on Geriatric Cardiology. (1996) (0)
Mo-P5:344 Cost-effectiveness of intensive lipid-lowering treatment with atorvastatin 80MG versus 10MG in secondary cardiovascular prevention in the UK (2006) (0)
Abstract 15658: Determinants of Residual Risk in 9,251 Secondary Prevention Patients Treated with High- versus Low-dose Statin Therapy: The Treating to New Targets (TNT) Study (2011) (0)
Pioneer series Tailoring cardiovascular risk assessment and prevention for women : One size does not fit all (0)
Faculty Opinions recommendation of Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003-2010. (2017) (0)
Atrial Fibrillation: A Much Needed Update (2005) (0)
Reimbursement for cardiac rehabilitation services. (1997) (0)
Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists (2016) (0)
POSTMENOPAUSAL HORMONE REPLACEMENT. AUTHORS' REPLY (1998) (0)
Rehabilitation after myocardial infarction: the responsibility of the primary physician. (1975) (0)
GENDER DISPARITY IN CORONARY HEART DISEASE: BIAS, BIOLOGY, OR BOTH? (2014) (0)
Diagnostic procedures: electron beam tomography and multislice computed tomography (2005) (0)
Thrombolytic therapy in the management of venous thromboembolism. (1983) (0)
Why Does Myocardial Infarction Preferentially Disadvantage Women? (2020) (0)
Presentation title to be advised (2012) (0)
Preventive coronary interventions for women : Exercise and cardiovascular disease risk in women : interaction with selected endocrine factors (1996) (0)
The Quest for Excellence in Cardiac Rehabilitation: Responsibilities of Health-Care Professionals to Their Patients (1987) (0)
Correction: Benefits and Harms of Intensive Blood Pressure Treatment in Adults Aged 60 Years or Older (2020) (0)
Faculty Opinions recommendation of Contemporary Trends and Age-Specific Sex Differences in Management and Outcome for Patients With ST-Segment Elevation Myocardial Infarction. (2017) (0)
Drug treatment of cardiovascular problems at elderly age. (2002) (0)
Leadless Pacemakers: State of the Art and Selection of the Ideal Candidate. (2023) (0)
Ability, disability, and the functional capacity of patients with cardiovascular disease. (1991) (0)
Prediction of cardiovascular events in statin-treated patients by lipid and non-lipid biomarkers (Retraction of vol 57, pg 63, 2011) (2013) (0)
Invasive management of the coronary patient: Coronary bypass surgery and coronary angioplasty. In memoriam Andreas Grüntzig. (1986) (0)
Do the 10-Year Mortality Outcomes of RITA-3 Inform Contemporary Clinical Practice? (2016) (0)
Paroxysmal tachycardias in infants. (1963) (0)
Reflections of a "lady doctor". (2003) (0)
New frontiers in cardiovascular aging. (2003) (0)
Survey of Sudden Death in the Offices of Atlanta Physicians and Dentists (1976) (0)
Exercise and Cardiac Rehabilitation in the Elderly (1984) (0)
cAn Official Journalof thecAmerican Heartc,tssociation, Inc. CURRENT TOPICS Physician Practice intheManagementofPatients withUncomplicated Myocardial Infarction: Changes inthePastDecade (1982) (0)
Coronary Disease in the Elderly (2001) (0)
Heart Disease: A Consensus Statement From the American Heart Association Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Ischemic (2014) (0)
Coronary Heart Disease in Women: Status 1998 (1999) (0)
Faculty Opinions recommendation of Achieved systolic blood pressure in older people: a systematic review and meta-analysis. (2020) (0)
Faculty Opinions recommendation of Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort. (2020) (0)
The Georgia Heart Clinic System: three decades of service. (1979) (0)
Cardiovascular disease and pregnancy: maternal cardiac disease: the obstetrician's viewpoint (1995) (0)
Myocardial infarction in women: Edited by Michael Stone, Anders Vedin, Claes Wilhelmsson Churchill Livingstone, Edinburgh (1986) 226 pages, illustrated, $55.00 ISBN: 0‐443‐03743‐4 (1988) (0)
P269 EFFICACY OF EZETIMIBE ADDED TO ATORVASTATIN VS. UPTITRATION OF ATORVASTATIN IN SUBGROUPS OF PATIENTS 65–74 YEARS AND ≥ 75 YEARS OLD (2010) (0)
Not your grandparents' cardiac care: The future of geriatric cardiology (2019) (0)
215: Effect of 80 mg Versus 10 mg of Atorvastatin in Patients >= and <65 Years of Age With Stable Coronary Heart Disease (2007) (0)
Seniors on the Sidelines: A Call for Action. (2020) (0)
Hormone treatment: misconceptions and agreements. Authors' reply (2002) (0)
Faculty Opinions recommendation of Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial. (2020) (0)
Medicare drug therapy in the elderly: pharmacotherapy, politics, and economics at the crossroads. (2005) (0)
Mechanical Properties and Function of Pericardium E-23-638 Sponsored Project Initiation $4,06 (partially Funded at $2,200 through 12/31/78) Terminal Report Contractual Matters (2010) (0)
212: Intensive Lipid Lowering With Atorvastatin is Associated With Significant Cardiovascular Benefits in Patients With and Without Chronic Kidney Disease (2007) (0)
Cardiac Rehabilitation-Reply (1980) (0)
Faculty of 1000 evaluation for Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis. (2016) (0)
The Institute of Medicine Report, Women’s Cardiovascular Health, and Evidence-Based Medicine (2004) (0)
A statement on ethics from the HEART group (2008) (0)
Sauce for the Goose Versus Sauce for the Gander: Should Men and Women Play the Same Game But With Different Rules? (2018) (0)
HRT USE BY WOMEN PHYSICIANS (1998) (0)
Faculty Opinions recommendation of Gender differences in all-cause, cardiovascular and cancer mortality during long-term follow-up after acute myocardial infarction; a prospective cohort study. (2018) (0)
Faculty Opinions recommendation of Cardiac Medication Use in Patients with Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease. (2018) (0)
We remember: C. Richard Conti, MD (2022) (0)
Faculty Opinions recommendation of Revascularization vs. Optimal Medical Therapy in Women with NSTE-ACS. (2018) (0)
[Stratification of risk after myocardial infarct: a more objective amplification of "clinical judgment"]. (1985) (0)
Faculty Opinions recommendation of Frequency of cardiovascular events in women with a congenitally bicuspid aortic valve in a single community and effect of pregnancy on events. (2011) (0)
Introduction: Long-Term Management of Patients After Myocardial Infarction (1988) (0)
Task Force 2: The physician in the office (adult medicine). (1981) (0)
Faculty Opinions recommendation of Applying the systolic blood pressure intervention trial results to older adults. (2020) (0)
The Very Elderly Patient: What Data Are Available to Guide Best Judgments? (2003) (0)
Scientific meeting on critical evaluation of cardiac rehabilitation: conference summary. (1976) (0)
Faculty Opinions recommendation of Use of Outpatient Cardiac Rehabilitation Among Heart Attack Survivors - 20 States and the District of Columbia, 2013 and Four States, 2015. (2018) (0)
Faculty Opinions recommendation of Gender differences in presentation, coronary intervention, and outcomes of 28,985 acute coronary syndrome patients in victoria, australia. (2018) (0)
Organising committee (2015) (0)
Atrial fibrillation: many therapeutic options, but great uncertainty about optimal treatment. (2002) (0)
Ventricular demand pacemaker inhibition by an atrial fixed rate pacemaker. (1972) (0)
Atlanta's Grady Hospital: management of cardiac patients in an urban public hospital. (1979) (0)
Atrial fibrillation in the elderly (2018) (0)
Suspected but unconfirmed acute myocardial infarction--"quo tandem Catalina nostra patientia vos abutere?". (1992) (0)
Stop and look--before you listen: non-cardiac clues to the diagnosis of cardiovascular disease. (1970) (0)
• New Guidelines on the Prevention of Heart Disease: An Update • A Healthy Sex Life Promotes a Healthy Heart. For more information about specific session times, contact Marlene Moni. (2012) (0)
Medication Dosing and Adherence in Secondary Prevention (2019) (0)
Faculty Opinions recommendation of Hypertension in the frail elderly. (2020) (0)
Association/American Association for Cardiovascular and Pulmonary Rehabilitation Prevention Programs : A Scientific Statement From the American Heart Medical Director Responsibilities for Outpatient Cardiac Rehabilitation/Secondary (2012) (0)
Quality of life concerns in the rehabilitation of patients with cardiovascular disease. (1986) (0)
Long-Term Care and Surveillance of the Patient Following Coronary Angioplasty or Coronary Bypass Surgery (1988) (0)
Data-driven clinical care. (2003) (0)
Meet Our Editorial Board Member (2018) (0)
Abstract 341: Optimizing Cardiovascular Disease Research in Women (2014) (0)
Denial of standard treatment to the elderly: why? (2007) (0)
PCV28 COST-EFFECTIVENESS OF INTENSIVE LIPID-LOWERING TREATMENT IN SECONDARY CARDIOVASCULAR PREVENTION IN SPAIN AND GERMANY (2006) (0)
Faculty of 1000 evaluation for Musculoskeletal health, frailty and functional decline. (2016) (0)
Faculty Opinions recommendation of Outcomes of intensive blood pressure lowering in older hypertensive patients. (2020) (0)
Pulmonary Rehabilitation American Heart Association/American Association for Cardiovascular and the Rehabilitation/Secondary Prevention Programs: A Scientific Statement From Medical Director Responsibilities for Outpatient Cardiac (2006) (0)
Devices for the Ailing Heart (2007) (0)
INTENSIVE LIPID LOWERING WITH ATORVASTATIN IS ASSOCIATED WITH SIGNIFICANT CARDIOVASCULAR BENEFITS IN CORONARY PATIENTS WITH DIABETES AND CHRONIC KIDNEY DISEASE (2008) (0)
The Cardiovascular Health Study: a national treasure of cardiovascular information about the elderly. (2004) (0)
Informed consumerism--education of the cardiac patient in the twenty-first century. (1989) (0)
Coronary heart disease in women: status 1992. (1992) (0)
Cardiovascular drugs: effects on exercise testing and exercise training of the coronary patient. (1985) (0)
Hormone treatment - Misconceptions and agreements [4] (multiple letters) (2002) (0)
Contents Vol. 65, 1980 (1980) (0)
Infectious myocarditis. (1972) (0)
Robert Carl Schlant, MD, 1929–2002 (2004) (0)
Clinical trial evidence for lipid lowering in women (2002) (0)
Chapter-15 Stable Ischemic Heart Disease in Women (2015) (0)
Does coronary bypass surgery prolong life? An incomplete question. (1981) (0)
Management strategies of dyslipidemia in the elderly: 2005. (2005) (0)
Chronic kidney disease is a cardiovascular problem--implications for lipid management. (2004) (0)
Faculty Opinions recommendation of Cardiac Rehabilitation after an Acute Coronary Syndrome: The Impact in Elderly Patients. (2018) (0)
Abstract: 26 HIGH-DOSE ATORVASTATIN PROVIDES SUSTAINED BENEFIT IN REDUCING RISK OF CV DISEASE AMONG STABLE CHD PATIENTS ≥65 YEARS (2009) (0)
Let us enroll the obstetrics/gynecology community in our vision of cardiovascular prevention for women (2020) (0)
Introduction: Past, Present, and Future of Heart Disease in Men and Women (2021) (0)
Faculty Opinions recommendation of Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes. (2018) (0)
Faculty Opinions recommendation of Apixaban versus warfarin in patients with atrial fibrillation. (2016) (0)
Cardiovascular Disease in Women ( VIII ) Menopausal Hormone Therapy and Cardiovascular Disease (2018) (0)
Rehabiliation after mycardial infraction: progonostic features and sycological consideration (1985) (0)
Impact of female sex on lipid lowering and relationship of lipids to clinical outcomes in atorvastatin trials (2013) (0)
Faculty Opinions recommendation of The amyloidogenic V122I transthyretin variant in elderly black Americans. (2016) (0)
Why Are We Not There Yet? (2021) (0)
Intervention Committee, Council on Cardiovascular Radiology and Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Coronary Artery Disease: Consensus Statement From the Cardiac Imaging Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected (2006) (0)
Coronary heart disease in the elderly : Working Conference on the Recognition and Management of Coronary Heart Disease in the Elderly, held September 4-6, 1985, at the National Institutes of Health, in Bethesda, Maryland, U.S.A. (1986) (0)
Faculty Opinions recommendation of The relationship between adherence to a Dietary Approach to Stop Hypertension (DASH) dietary pattern and insomnia. (2020) (0)
Modern cardiac electrophysiology and the elderly. (2005) (0)
Faculty Opinions recommendation of Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. (2009) (0)
C. Richard Conti—Lifelong learning: Advocacy and implementation (2022) (0)
Panel II: The pros and cons of early mobilization and of the convalescent phase in rehabilitation. (1976) (0)
Abstract 17209: Impact of Female Sex on Discontinuation Rates and Creatine Kinase Elevations in Atorvastatin Trials (2013) (0)
Patient and Family Education: A Requisite Component of Comprehensive Rehabilitation after Myocardial Infarction (1980) (0)
The TNT study, women and cancer (2009) (0)
Clinical guidelines for cardiovascular disease prevention: Should they differ by gender? (2007) (0)
Preventing coronary heart disease in women: What you-and your patients-can do (2002) (0)
The value of exercise in the practice of medicine. (1979) (0)
Meet Our Editorial Board Member (2020) (0)
Nanette Kass Wenger, MD: a conversation with the editor [interviewed by William Clifford Roberts]. (2003) (0)
Robert A. Bruce, MD: Scientist, Clinician, Teacher, Mentor, and Friend (2004) (0)
Women2011 Update: A Guideline From the American Heart Association Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in (2011) (0)
Primary myocardial disease: clinical characteristics. (1970) (0)
Newer diagnostic strategies, application of evidence-based therapies: improving cardiovascular outcomes in an expanding elderly population. (2007) (0)
AHA/ACOG PRESIDENTIAL ADVISORY Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists (2018) (0)
Physical activity, exercise testing, and exercise training programs for patients with myocardial infarction: the state of our knowledge. (1973) (0)
Angina/Non ACC/AHA 2007 Guidelines for the Management of Patients With Unstable (2011) (0)
Risk Factors and the Prevention of Heart Disease (2003) (0)
Hypertension management in older adults [version 1; peer review: 5 approved] (2022) (0)
Faculty Opinions recommendation of Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data. (2018) (0)
Common pitfalls of perfusion lung scan interpretation. (1976) (0)
The synthesis of humanism and medical science: Herrman Ludwig Blumgart, 1895–1977—teacher, physician, administrator, scientist (1992) (0)
Faculty Opinions recommendation of Effect of discontinuation of antihypertensive medication on orthostatic hypotension in older persons with mild cognitive impairment: the DANTE Study Leiden. (2020) (0)
Coronary Heart Disease in Women: Diagnosis, Evaluation, and Preventive Therapy (2007) (0)
Faculty of 1000 evaluation for Rational dispersion for the introduction of transcatheter valve therapy. (2016) (0)
Exercise and Cardiac Rehabilitation in Elderly Patients (1987) (0)
Cardiac Rehabilitation Exercise Video Series (1988) (0)
Title Page / Contents / List of Contributors / Dedication / Preface / Introduction (1986) (0)
Mo-P1:167 Younger menopause age predicts adverse outcome after myocardial infarction (2006) (0)
Management of heart failure (1986) (0)
Abstract: P773 EFFICACY OF EZETIMIBE ADDED TO ATORVASTATIN VS UPTITRATION OF ATORVASTATIN IN THE ELDERLY (2009) (0)
Rehabilitation: a component of comprehensive cardiac care. (1986) (0)
Women, Hypertension, and the SPRINT (2016) (0)
214: Effect of Intensive Cholesterol Lowering With Atorvastatin in Patients with Previous Coronary Bypass Surgery: A Treating to New Targets (TNT) Substudy (2007) (0)
13. Cardiovascular Problems in Elderly Patients (2016) (0)
Faculty Opinions recommendation of Long-Term Survival Among Patients With Myocardial Infarction Before Age 50 Compared With the General Population: A Danish Nationwide Cohort Study. (2018) (0)
Hormone Replacement Therapy in Postmenopausal Women: Does It Lessen Coronary Heart Disease Risk? (1996) (0)
THE ELECTROCARDIOGRAM OF THE NORMAL NEWBORN INFANT. (1965) (0)

This paper list is powered by the following services:

Other Resources About Nanette Wenger

en.wikipedia.org

What Schools Are Affiliated With Nanette Wenger?

Nanette Wenger is affiliated with the following schools:

Nanette Wenger's Academic­Influence.com Rankings